EAS 2025 at a glance
Prepare for EAS 2025 with LucidQuest’s quick preview, highlighting can’t-miss sessions and new trends in cardiometabolic science and AI.
📅 Build your schedule around the topics that interest you. 📥 Download EAS 2025_Preview_by_LucidQuest
Dive deeper
Key Topics From EAS 2025 Scientific Presentations
Lipid Lowering
- siRNA, next-gen PCSK9, and fixed-dose combos reshape dyslipidemia care; real-world gaps spotlight guideline updates. 💊📉
Atherosclerosis
- Immune-metabolic drivers mapped via multi-omic profiling, opening doors to disease-halting interventions. 🧬🛑
Cardio-Risk
- SGLT2i, Lp(a) agents, and RNA therapeutics pair with sex- and gene-based risk scoring for bespoke prevention. 🎯🔍
Diabetes & Metabolic Syndrome
- Arterial stiffness, plaque burden, and liver dysfunction tie T2D/obesity to CV risk; novel biomarkers guide therapy across diverse populations. 🍽️⚖️
Clinical Trials
- Early, intensive LDL-C lowering, universal pediatric screening, and emerging markers (remnant-C, apo-variability) sharpen prediction models. 🧪📊
Genomics
- Gene therapy, transcriptomics, and CRISPR screens refine diagnoses and seed first-in-class lipid/vascular treatments. 🧬🚀
Imaging
- Next-gen CTA, FAI scoring, and functional tests deliver non-invasive, real-time plaque activity mapping. 🖥️🔦
Inflammation
- Anti-inflammatory targets meet lipid modulation to arrest chronic vascular inflammation. 🔥🛡️
Industry Spotlights
- MENARINI Group — novel CETP inhibition to close residual-risk gaps.
- Ultragenyx / Chiesi Group — HoFH pathways & evinacumab real-world impact.
- Amarin Corporation — REDUCE-IT data propel icosapent ethyl guideline expansion.
- Daiichi Sankyo — MILOS study underlines oral combo strategies. 📈🤝
Artificial Intelligence and Machine Learning Themes at EAS 2025
Predictive AI
- 20-yr #ATTICA model flags long-term CV risk & silent dyslipidemia early. 📐🤖
Imaging AI
- Deep-learning segmentation sharpens coronary & perivascular CTA; AI-based FAI scores guide angina care. 🩻🧠
ML Diagnosis
- Algorithms predict stenosis, triage angiography, and curb unnecessary caths. 🔎💡
Digital Prevention
- AI-powered platforms marry wearables & omics for personalized prevention plans. 📲🧬
Multimodal AI
- Integrated plaque volume + biochemical models redefine athero phenotyping—including cardio-risk signals in early Parkinsons. 🧩🔬
📅 Build your schedule around the topics that interest you.